Page 5 - Active Ingredient News Today

The Food and Drug Administration announced approval of the Eli Lilly drug for weight loss on Nov. 8.

U.S. officials declared on Wednesday that a new version of the well-liked diabetic therapy Mounjaro can be marketed as a medication for weight reduction.

The once-weekly injection, which contains the same active ingredient as Lilly's big-selling type 2 diabetes treatment Mounjaro, will be sold under the brand name Zepbound. Like Wegovy, the FDA approved Zepbound for adults who are considered obese using a measure known as body mass index (BMI), a ratio of weight to height. The GLP-1 class of drugs like Wegovy, Novo's related Ozempic and Zepbound were originally developed to help control blood sugar in patients with type 2 diabetes but...

Fall is a good time to test landscape and garden soils. It’s a great time to incorporate organic matter to improve soil structure, and if attempting to lower soil pH,

Austria’s health authorities said they had reports that Ozempic counterfeit medicine had reached patients. UK regulators also said a small number of patients were hospitalised.

Health officials in Austria are the latest to warn the public to stay away from sketchy sources of semaglutide, the active ingredient in popular weight loss drugs Wegovy and Ozempic, following recent reports of severe adverse effects linked to counterfeit products. Residents have reportedly been hospitalized with dangerously low blood sugar and seizures after taking these drugs, which may have actually contained insulin.

Dublin, Oct. 27, 2023 (GLOBE NEWSWIRE) -- The

Dr Reddy's Laboratories on Friday reported a 33.02 per cent increase in consolidated profit after tax at Rs 1,482.2 crore in the second quarter ended September 30, led by the US generics market.

Dr Reddy's Laboratories Q2 Results: The consolidated total revenue from operations was at Rs 6,902.6 crore, up 9 per cent, compared to Rs 6,331.8 crore in the year-ago period

Reading ingredient labels closely will help consumers make more informed decisions. ljubaphoto/E+ via Getty ImagesThe ramp-up to cold and flu season is a bad time for consumers to learn that some of their most trusted go-to products don’t actually work. An advisory committee to the U.S. Food and Drug Administration concluded unanimously in September 2023 that phenylephrine – an active ingredient found in popular over-the-counter cough and cold products such as Sudafed PE, Theraflu ...